Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 9Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 7Rectal Neoplasms 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Lymphocytic, Chronic, B-Cell 6Hodgkin Disease 6Congenital Abnormalities 6Colonic Neoplasms 6Burkitt Lymphoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, T-Cell, Cutaneous 4Lymphoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Leukemia 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Waldenstrom Macroglobulinemia 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3

Interventions

Polymorphism, Single Nucleotide 2Neoadjuvant Therapy 2Amplified Fragment Length Polymorphism Analysis 2elacestrant 1Surgical Procedures, Operative 1Dexmedetomidine 1DEAE-Dextran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Cancer Patients × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT04654195 2020-12-04

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Damanhour University

Unknown
100 enrolled
Breast

Breast Cancer Patients

NCT04581967 2020-10-09

Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients

Damanhour University

Unknown
100 enrolled
Breast

Breast Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡